A novel pre clinical approach to evaluating tumor oxygen dynamics was recently introduced (Am. J. Clin. Oncol. 24, 462-466 (2001)). FREDOM (Fluorocarbon Relaxometry using Echo planar imaging for Dynamic Oxygen Mapping) allows maps of tumor pO 2 including 50 -150 individual locations simultaneously to be produced with typical in plane resolution of 1.25 mm in 6.5 mins. The technique has been applied extensively in rat prostate tumors and is now demonstrated in the rat breast 13762NF adenocarcinoma. When anesthetized rats breathed 33% oxygen, mean baseline pO 2 was in the range 17 ± 2 (se) torr to 74 ± 4 torr with mean value for nine tumors 46 ± 8 torr. However, small tumors (< 2.2 cm 3 ) were significantly better oxygenated with mean pO 2 = 63 ± 7 torr than large tumors (> 2.4 cm 3 ) with mean pO 2 24 ± 5 torr (p< 0.002). Switching the inhaled gas to oxygen or carbogen produced a significant and rapid increase in mean pO 2 for both small and larger tumors (p< 0.05). Given the increasing evidence that tumor oxygenation is related to therapeutic outcome, we believe this approach to measuring tumor oxygen dynamics can be of value in predicting response to therapy, evaluating adjuvant interventions designed to modulate response to therapy, and in providing "Prognostic Radiology".
Introduction
The critical effects of oxygenation on tumor therapy, angiogenesis, metastasis, and prognosis have stimulated the development of diverse novel tumor oximetry techniques (1). These include polarographic needle electrodes (2, 3) and luminescencebased optical sensors (4, 5), which invasively report pO 2 . Reporter molecules have been developed for use with ESR/EPR (Electron Spin Resonance) (6, 7), phosphorescence imaging (8), PET (Positron Emission Tomography) (9) or SPECT Single Photon Emission Computed Tomography) (10). NMR (Nuclear Magnetic Resonance) offers alternative approaches, e.g., 31 P NMR of endogenous metabolites provides an indication of metabolic hypoxia based on phosphorylation potential, but is not necessarily a direct indication of pO 2 (11, 12) . BOLD (Blood Oxygen Level Dependant) contrast proton MRI is sensitive to vascular oxygenation (13). Dynamic contrast enhancement kinetics following infusion of small paramagnetic agents such as Gd-DTPA may be related to oxygenation (14) (15) (16) . In addition, pO 2 may be directly measured using 19 F NMR of perfluorocarbons (PFCs) (17) (18) (19) . 19 F NMR oximetry is based on the principle that the 19 F NMR spin-lattice relaxation rates R1 (1/T1) of PFCs are strongly dependent on, and linearly proportional to, oxygen tension (18) . Moreover, R1 is insensitive to other influences such as ions and protein concentrations, which alter the R1 of aqueous materials (20) . This arises from the extreme hydrophobicity of PFCs, which form isolated droplets in aqueous media, effectively insulating the fluorine nuclei from many interactions that might affect R1. Dissolved gases, such as oxygen can, however, penetrate the fluorocarbon, and thus, significantly influence the observed R1 value, due to the dipole-dipole interaction between the electron spin of the oxygen molecule and the nuclear spin of the fluorine nucleus. The relationship R1= a + bpO 2 is sensitive to temperature and magnetic field and the relevant calibration curves are required, but these can be established a priori in solution (19, 21) . While many PFCs have been applied to tissue oximetry (18, 22) , we favor hexafluorobenzene (HFB), which is readily available, cheap and non-toxic. It has a single 19 F NMR resonance due to its symmetry, high sensitivity to changes in pO 2 and yet minimal response to changes in temperature (19) .
The FREDOM approach (Fluorocarbon Relaxometry using Echo planar imaging for Dynamic Oxygen Mapping) generates maps with typically 50 -150 individual locations simultaneously in 6.5 mins. Using HFB as the reporter molecule, a typical precision of 1 to 3 torr can be achieved for low pO 2 values. In the past, we have conducted extensive investigations in rat prostate tumors (3, 17, 23, 24) and we now demonstrate the technique in rat breast tumors, specifically 13762NF adenocarcinomas (25). We specifically investigated interventions anticipated to modulate tumor tissue pO 2 .
Materials and Methods

Animal Preparation
Rat mammary adenocarcinomas 13762NF (obtained from the Division of Cancer therapeutics, NCI) were implanted in skin pedicles on the foreback of adult female Fisher 344 rats (~ 250 g, n = 9) (26). When the tumors reached an appropriate size (1 -5 cm 3 ), the rats were anesthetized with ketamine hydrochloride i.p. (200 µl; 100 mg/ml; Aveco, Fort Dodge, IA) and were maintained under general gaseous anesthesia using a small animal anesthesia unit with 33% O 2 , 66% N 2 O, and 0.5% methoxyflurane at a flow rate of 1 dm 3 /min. Tumor hair was trimmed for the ease of HFB injection. Hexafluorobenzene (40 µl, 99.9%, Aldrich Chemical Co., St. Louis, MO) was injected directly into selected central and peripheral regions of the tumors in a single plane using a Hamilton syringe with a fine sharp 32 G needle. The needle was inserted manually to penetrate across the whole tumor and withdrawn ~ 1 mm to reduce the tissue pressure and 2~5 µl HFB injected. The needle was repeatedly withdrawn 1~2 mm and further HFB injected. A total of 2 ~ 3 tracks of HFB were injected in the form of a fan. The rats were placed in the magnet on their sides and body temperature was maintained using a warm water blanket. An NMR compatible fiber optic pulse oximeter (Nonin Medical, Inc., Plymouth, MN) was placed on the hind foot to monitor arterial hemoglobin saturation (s a O 2 ) and a fiber optic temperature probe (Luxtron, Mountain View, CA) was inserted rectally to monitor core temperature.
MRI
MRI was performed using an Omega CSI 4.7 T horizontal bore system equipped with actively shielded gradients (Acustar™, Bruker Instrument, Inc., Fremont, CA). A size matched tunable 1 H/ 19 F single turn solenoid coil was placed around the tumor. Shimming was performed on the tumor tissue water to a typical linewidth of 70 Hz and 3-D 1 H MRI performed at 200.106 MHz. T2-weighted images were acquired with TR = 1500 ms, TE = 80 ms and 128×64×8 points over 20×20×20 mm giving 156×312×2500 µm resolution. Following 1 H MR imaging, the corresponding 19 F MR imaging (188.273 MHz) was performed to show the distribution of HFB in the tumor. Fluorine density-weighted images were acquired as a 3-D data set using a driven-equilibrium spin-echo pulse sequence with TR = 150 ms, TE = 8 ms and the same resolution as for 1 H MRI. Data were processed using sine-bell apodization.
Oximetry FREDOM used an MBEST spin echo planar imaging sequence with pulse burst saturation recovery (PBSR) signal preparation, a variable recovery time and spin echo acquisition (27). To enhance the signal to noise ratio, and thus, improve the precision of R1 measurements the ARDVARC (Alternated R1 Delays with Variable Acquisitions to Reduce Clearance effects) protocol was applied (24). R1 was calculated on a voxel by voxel basis using a Levenberg Marquardt 3 parameter fit and pO 2 was estimated using the equation pO 2 = (R1-0.0835)/0.001876, as described in detail previously (24).
A series of three baseline pO 2 maps was generated over 24 mins for all nine tumors and then seven rats were exposed to varying inhaled gas according to the challenge paradigm:
Five measurements were taken for each gas switch with no equilibrtation period. A total of 23 maps was obtained duing a complete five-phase imaging session over 2.5 hours. Data were evaluated using Fisher's PLSD (Protected Least Squares Difference) Matched pairs ANOVA (Analysis of variance) (Statview, SAS Inst.) or Students t test and differences of p < 0.05 were considered statistically significant.
Results
13762NF breast tumors grew with an apparent volume doubling time in the range 6.2 to 8.2 (mean 7.3 ± 0.6) days. However, even small tumors were found to have substantial necroses (e.g., Fig. 1 ). T2 weighted 1 H MR images also indicated substantial heterogeneity (Fig. 2) . Corresponding 19 F MR images revealed the discrete distribution of HFB in the tumor with typically about ~ 7% of the total tumor voxels providing 19 F NMR signal. Representative pO 2 maps are shown in Figure 3 for baseline conditions and during oxygen and carbogen breathing. Gray background represents all voxels that fitted the three-parameter exponential relaxation model. However, even random electronic noise may give an apparent curve, and thus, thresholds were applied to the raw pO 2 maps. Only those voxels providing consistently high quality data throughout the study were included, e.g., the 52 colored voxels. Figure 4 shows the time course profile of mean pO 2 in response to respiratory challenge for tumor #1.
Baseline measurements (breathing 33% O 2 ) were generally stable: mean pO 2 = 19.4 ± 2.6, 19.6 ± 2.8, and 15.6 ± 2.1 (torr), respectively for three measurements in tumor #1. There was a strong linear relationship between both mean baseline pO 2 or hypoxic fraction (HF 10 ) and tumor volume ( Fig. 5 ).
Breathing 100% oxygen induced rapid and significant changes in pO 2 . Following the switch to oxygen breathing, tumor oxygen tension increased to 69 ± 12 torr within 8 mins (p < 0.01) and continued to increase further yielding 100 ± 22 torr by 24 mins and 167 ± 40 torr by 40 mins (p < 0.005). After the gas was switched back to baseline (33% O 2 ), pO 2 dropped quickly and significantly within 8 mins (p < 0.01), and then slowly, thereafter, for the next 30 mins. Altering inhaled gas to carbogen produced a similar pO 2 time course response pattern in terms of the rate of response and magnitude, and the final pO 2 value was not significantly different from breathing oxygen. Upon return to 33% O 2 breathing for the last phase of the experiment, pO 2 returned to the baseline level again, indeed, more rapidly than following oxygen breathing. For the group of 5 small tumors (< 2.2 cm 3 ) mean baseline pO 2 = 63 ± 7 torr, which increased to 136 ± 9 torr with oxygen breathing and 157 ± 14 torr with carbogen. Large tumors (> 2.4 cm 3 ) were significantly less well oxygenated (p < 0.002) with baseline pO 2 = 24 ± 5 torr rising to 81 ± 6 torr with oxygen and 72 ± 10 torr with carbogen. Meanwhile, arterial Sa O2 rose from a baseline value of 90.1 ± 1.7% to 97.6 ± 0.4% during carbogen inhalation.
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Heterogeneity of tumor oxygenation is shown by the histograms in Figure 6 . For this tumor, pO 2 distribution concentrated on the low pO 2 range with a mean pO 2 = 20 ± 2 torr and a median pO 2 =10 torr, while the rat was breathing 33% O 2 . Oxygen breathing caused a significant shift of the histogram towards higher pO 2 values (p < 0.001), yielding a mean pO 2 = 80 ± 8 torr and a median pO 2 = 68 torr for the period of oxygen breathing. Carbogen breathing also caused a significant shift of the histogram towards higher pO 2 values (p < 0.0008), giving a mean pO 2 = 121 ± 14 torr and a median pO 2 = 116 torr. In this study, all seven tumors showed a significant increase in pO 2 when the rats inhaled either 100% O 2 or carbogen, although the rise varied between individual tumors (Fig. 7) . Generally, tumors with lower baseline pO 2 responded less to either 100% O 2 or carbogen breathing compared to those with higher baseline.
A major strength of the FREDOM technique is the ability to repeat pO 2 measurements non-invasively, e.g., Figures 3, 4 and 7. Moreover, it is possible to trace the fate of individual voxels (regions) with respect to interventions (Fig. 3) . A strong linear correlation was observed in most of the 13762NF breast tumors between initial mean baseline pO 2 and the maximum pO 2 achieved at the same location (voxel) with respect to carbogen or oxygen breathing, e.g., 83 voxels in breast tumor # 1 (Fig. 8) .
Discussion
We have previously demonstrated the application of FRE-DOM to monitor tumor oxygen dynamics in prostate tumors and now show application to rat breast tumors with respect to interventions. As before, we found stable baseline pO 2 values in these tumors, but with a large range indicating distinct heterogeneity. In general, pO 2 values found in the breast tumors were somewhat higher than in comparably sized Dunning prostate R3327 rat tumors under similar anesthesia (33% oxygen; 0.5% methoxyflurane). Indeed, similarly sized small tumors of various sublines with diverse growth rates showed baseline pO 2 =37 ± 0.8 torr (AT1, undifferentiated, volume doubling time (VDT) = 5 days, 32 torr (HI, moderately differentiated, VDT = 9 days and 25 torr (MAT-Lu, VDT = 2.7 days) (3, 24). As seen here, larger tumors were significantly less well oxygenated, although the prostate tumor investigations used somewhat larger tumors ("big" >3.5 cm 3 ). Decreasing oxygenation and increasing hypoxia is a characteristic of many tumors reported also by other investigators (28, 29) . Some clinical investigations have also shown progressive hypoxiation with tumor size (30-32), while other investigations have not found this effect. We believe this may be related to absolute tumor size, since many clinical tumors are > 5 cm 3 and often reach 50 or 100 cm 3 at time of investigation (30, (33) (34) (35) . In a recent study of the Dunning prostate R3327-HI tumors with respect to growth, we found a catastrophic decline in pO 2 with growth occurred in the range 1 to 2 cm 3 (4).
Response to elevated oxygen breathing was highly significant and essentially all tumor regions (voxels) responded whatever the baseline pO 2 . However, those with initially higher baseline responded much faster and to a greater extent. Indeed there was a linear relationship between baseline pO 2 and that achieved with hyperoxic gas. This might suggest that baseline pO 2 measurements could indicate the utility of gas inhalation as an adjuvant to improve response to tumor irradiation. However, we note that the response varies between tumor types, e.g., in Dunning prostate R3327 AT1 tumors, investigated previously, only those regions with pO 2 initially greater than 10 torr responded to hyperoxic gas breathing, whereas those with relatively hypoxic baseline did not (24). By contrast, the relatively well differentiated HI tumor type showed significant response whatever the initial baseline and even hypoxic regions responded rapidly and substantially (4). As found for other rat tumors implanted in pedicles, both oxygen and carbogen elicited very similar response (3, 24).
Other PFCs have been used in the past for NMR oximetry, e.g., 15-crown-5-ether (14, 36) , perfluoro octyl bromide (37) and perfluorotributylamine (38). However, we favor HFB, which has many strengths including a single sharp 19 F NMR signal, high sensitivity to changes in pO 2 and little response to temperature (19) . HFB is commercially available and there is an extensive literature confirming lack of toxicity (39-41). Since HFB is highly volatile it is probably not suitable for emulsification, as favored for many other PFCs, and indeed it clears from animals quite rapidly. We have previously found a tumor tissue half-life ~ 600 mins (42), and hence, we favor the ARDVARC acquisition protocol, which minimizes any systematic bias on relaxation measurements due to signal clearance. Using neat PFC minimizes the volume for injection. Direct intra tumoral injection could cause vascular disruption and damage to tumor capsule or integrity, however, the exceptionally fine needle (32 G) and small volume of reporter molecule are minimally invasive.
Alternative methods may be used to explore tumor oxygenation. Near infra red spectroscopy (NIRS) rapidly and noninvasively reveals changes in vascular oxygenation, though currently there is little spatial resolution (43). BOLD contrast MRI is highly sensitive to changes in vascular oxygenation, but is also subject to variations in blood flow and volume (44). Since Gd-DTPA is routinely used in the clinic for tissue contrast and dynamic studies, several groups have examined the prognostic value of the DCE curves. In some cases the shape of the curve may be related to tumor stage (45, 46) and correlations between DCE and oxygen tension measured polarographically have been reported (15, 16) . Indeed, one approach using sophisticated mathematical modeling based on the Krogh cylinder representation of diffusion has shown a direct relationship between DCE contrast and pO 2 (14). While pO 2 gradients and diffusion characteristics may be evaluable, oxygen consumption is also a critical and highly variable parameter and will likely limit application of the approach. Likewise, BOLD and NIRS approaches provide rapid non-invasive indications of vascular oxygen delivery, but pO 2 , which is the clinically proven prognostic parameter for patient survival and response to therapy (2, 30) is related to the interplay of oxygen delivery and consumption (47).
In addition to tumor size, stage and pO 2 many prognostic indices have been reported often based on histological, genetic or proteomic assessment of biopsies, e.g., expression of Hif-1 (48), p53 (49) and RASSF1A (50) have been implicated in tumor progression and aggressiveness. Useful prognosis for tumor staging and response to therapy will likely require the interplay of diverse parameters combining multiple modalities including tumor proteomics, genetics, physiology, and architecture. Indeed, integrating diverse parameters, modalities, and scientific and medical disciplines is a primary goal of the NCI ICMIC program.
Currently, the FREDOM method has pre clinical application, but we propose to seek IND status in the near future for translation to the clinic. As higher field clinical MR systems (e.g., 3 and 4 T) with secondary amplifiers become more readily available imaging with hetero nuclei such as fluorine will become more facile. We believe that the FREDOM approach to monitoring pO 2 quantitatively can be of value for exploring therapeutic interventions (e.g., effects of vascular targeting agents (51) and adjuvant interventions designed to modulate pO 2 as with oxygen and carbogen here. Indeed, we recently showed that modulation of pO 2 by oxygen breathing and the induced elevation in pO 2 was strongly related to radiation induced tumor growth delay (52). As with any new technique further studies in multiple centers will be required to popularize the method for widespread application.
